The first meeting of the Moroccan Blood and Derivatives Agency’s Board of Directors was held on Wednesday in Rabat, chaired by Head of government Aziz Akhannouch.
This meeting focused on strategic aspects of the agency, established under Law 11.22 as part of the broader health system reform promoted by King Mohammed VI, in line with the Health System Framework Law 06.22.
The meeting saw the adoption of the agency’s annual action plan, 2025 budget, organizational structure, and staff regulations. Akhannouch emphasized that the agency’s creation supports the ongoing health reform and plays a critical role in ensuring adequate blood supply for all citizens, reflecting the government’s commitment to health equity and social solidarity.
Kamal Doghmi, director of the agency, highlighted the agency’s role in strengthening national sovereignty over blood products and its mission to meet evolving health needs through better coordination and management of blood stocks, especially in emergencies.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.